Canada: Medical device fees increased by 2% from 1 April 2019
Canada: ‘Medical Devices Regulations’ updated to refer to 2016 edition of ISO 13485
Canada: Public to have access to clinical information on drugs and devices
Canada: Consultation held on draft guidance concerning software as a medical device
Canada: Publication of Draft Health Canada IMDRF ToC for Medical Device Applications Guidance
Canada: Publication of updated list of recognised standards for medical devices
USA: New acting FDA Commissioner
USA: CDRH undergoes period of reorganisation
USA: Ventilatory electrical impedance tomograph classified into Class II (special controls)
USA: Posterior cervical screw systems become Class II devices
USA: In vitro diagnostic devices for Bacillus species detection placed in to Class II
USA: Class II classification for software applications for contraceptives
USA: Auto titration device for oral appliances is classified into Class II
USA: Class II classification for the transcranial magnetic stimulation system for neurological and psychiatric disorders and conditions
USA: Devices to detect and identify microorganisms and associated resistance marker nucleic acids directly in respiratory specimens are Class II devices
USA: Steps to reduce risks from use of surgical staplers for internal use and implantable staples
USA: Certain flow cytometer instruments to be exempted from 510(k) review
USA: Finalised list of accessories distinct from other devices and suitable for Class I
USA: Safety and performance based pathway described in final guidance
USA: Resources for implementing final rule on human subject protection; acceptance of data from clinical investigations for medical devices
USA: Certain unclassified medical devices are exempt from 510(k) requirements
USA: Guidance updated on post-market safety reporting for combination products
USA: New guidance covers issuing of public warnings about voluntary recalls and notification of recalls
USA: Guidance on evaluation of devices used with regenerative medicine advanced therapies
USA: Concept and principles of the least burdensome provisions are updated in guidance
USA: Updated guidance on devices containing materials derived from animal sources
USA: New guidance addresses coordinated development of antimicrobial drugs and AST devices
USA: Draft principles of pre-market pathways for combination products
USA: Standardised process for providing non-binding feedback after certain FDA device establishment inspections has been proposed
USA: Draft guidance on initiating voluntary product recalls
USA: Draft guidance recommends non-clinical testing and clinical considerations for implanted Brain-Computer Interface devices
USA: Review and update of device establishment inspection processes and standards
USA: Questions and answers drafted on a risk-based approach to monitoring clinical investigations
USA: Draft guidance issued on technical performance assessment of quantitative imaging in device pre-market submissions
USA: Technical considerations are proposed for non-clinical assessment of medical devices containing nitinol
USA: Proposed regulatory framework for modifications to artificial intelligence-/machine learning-based software as a medical device
USA: Modifications to the list of US FDA-recognised standards
USA: GUDID temporary grace period extension ends; HL7 SPL processing window reduced
USA: Clarification provided on difference between servicing and remanufacturing of medical imaging devices
Click here for the full article on Global Regulatory Press.
Contact us at info@arqon.com.